Tumor-associated antigen mucin 1 (MUC1) is overexpressed on many human epithelial tumor tissues, such as breast, ovarian, and prostate carcinomas, which makes it an attractive target for tumor immunotherapy (1, 2). The gene discussed is MUC1; the disease is neoplasm.